Xeris Pharmaceuticals Inc (XERS) News Headlines

▮ More

Date

Headline

3/11/2020 6:05:35 AM Xeris Pharma Q4 Net Loss Of $33.1 Mln Or $1.23/Shr Vs Loss Of $20.4 Mln Or $0.98/Shr Last Year

2/11/2020 7:31:41 PM Xeris Pharma Prices Underwritten Public Offering Of 9 Mln Shares At $4.15/shr

1/6/2020 8:45:51 PM LIFE Gets A Boost With Kyorin Deal, XERS Up 20% After-Hrs, ITCI On Watch

12/10/2019 8:28:55 PM FDA Panel Says No To CORV, ITRM For Sure Has Disappointed, ELOX, XERS On Watch

10/4/2019 6:15:36 AM New Drugs Approved In September

9/19/2019 8:09:16 AM Xeris Pharma Begins Dosing Patients In Phase 2 Clinical Trial Of Novel Fixed-Ratio Co-Formulation Of Pramlintide-Insulin

9/11/2019 1:40:20 AM 5 Top Losers In Healthcare Sector (EMMA, MBOT, XERS…)

9/9/2019 3:51:07 AM FDA Verdict On XERS - Go Or No Go?

8/26/2019 6:47:29 AM Biotech Stocks Facing FDA Decision In September 2019

6/27/2019 8:05:05 AM Xeris Doses First Subject In Phase 2 Trial With Ready-to-use Glucagon

6/6/2019 4:12:36 PM Xeris Pharmaceuticals Trading Expected To Resume At 4:30 PM ET

6/6/2019 4:03:41 PM Xeris Pharmaceuticals Trading Halted; Pending News

5/24/2019 11:16:57 PM Biotech Stocks Facing FDA Decision In June 2019

2/13/2019 7:54:24 PM Xeris Prices Public Offering Of 5.88 Mln Shares At $10.00/shr

12/20/2018 8:33:25 AM EMA Grants Orphan Drug Designation For Xeris’ Investigational Ready-to-Use Glucagon For Treatment Of NIPHS

11/7/2018 8:15:09 AM Xeris Pharmaceuticals Q3 Net Loss Widens To $14.8 Mln From $7.5 Mln Last Year

10/23/2018 8:35:57 AM Xeris Pharma Announces FDA Acceptance For Review Of NDA For Ready-to-Use Glucagon Rescue Pen

9/19/2018 10:58:47 PM UBX To Report Phase I Data In Q1, NVTA On Watch, NTGN Faces Busy Year Ahead

8/17/2018 8:31:16 AM Xeris Pharma And OHSU Conducting Artificial Pancreas Clinical Trial Using Xeris’ Novel Ready-to-Use Liquid Glucagon

8/14/2018 8:52:18 PM XERS Up 36% This Month, EVFM On Fast Track, NDRA Hitting Right Notes